Deuterated Water

DIAGNOSTIC_TEST3 trials

Sponsors

GlaxoSmithKline, Forma Therapeutics, Inc., Helsinki University Central Hospital

Conditions

CachexiaNon-alcoholic Fatty Liver Disease (NAFLD)Nonalcoholic Steatohepatitis (NASH)Overweight or Obesity

Phase 1

A Study to Evaluate a Skeletal-muscle Microbiopsy Technique With Dynamic Proteomic Measurement in Healthy Male Volunteers

CompletedNCT01962454

GlaxoSmithKlineCachexia

Start: 2014-05-05End: 2015-03-20Updated: 2017-05-09

A Study of FT 4101 in Overweight/Obese Participants With Non-alcoholic Steatohepatitis

TerminatedNCT04004325

Forma Therapeutics, Inc.Nonalcoholic Steatohepatitis (NASH), Overweight or Obesity

Start: 2019-05-17End: 2020-01-20Updated: 2025-10-20

Unknown Phase

Elucidating Hepatic Metabolism in Non-alcoholic Fatty Liver Disease

Enrolling by invitationNCT06942312

Helsinki University Central HospitalNon-alcoholic Fatty Liver Disease (NAFLD)

Start: 2025-05-01End: 2030-12-31Target: 30Updated: 2025-04-24